Jobs at Surmodics – meet the Medtech innovators at Jobs Expo Galway
Don’t miss your chance to learn about jobs at Surmodics at Jobs Expo Galway in February 2017.
Surmodics offers advanced technologies which enable as well as enhance medical devices and in vitro diagnostics. The company acts as a collaborative strategic partner offering solutions to their clients. As a result, they help their clients go from concept to commercialisation faster by leveraging their proven experience. Therefore, they improve patient lives and support customer objectives through technology innovation.
The company’s history of collaborative innovation began with three scientists. They came together to use their organic, photochemical, and immunodiagnostic expertise to develop and commercialise diagnostic and medical products.
History of Surmodics
Established as Bio-Metric Systems in 1979, Surmodics has since shifted its strategic objective from contract research to the commercialisation of its unique PhotoLink® surface modification and immobilization technologies. Furthermore, in 1990, they added the marketing of biomolecule stabilisation products.
In July 1997, the company changed its name to Surmodics, Inc. They became a public company on March 4, 1998.
In August 2007, Surmodics further broadened its product portfolio within the in vitro diagnostic market after they acquired BioFX Laboratories.
Today, Surmodics focuses its expertise in two ways:
- The Medical Device business unit is a leading provider of surface modification and drug delivery technologies in the areas of hydrophilic coatings and site-specific drug delivery.
- The In Vitro Diagnostics business unit specializes in the development and commercialization of products and technologies for the in vitro diagnostic market.
Surmodics in Ireland
In June 2016, Surmodics announced that they were to create 100 new jobs in Ireland over the next five years. The expansion is part of a major €7m investment by the company into its Irish facility. Furthermore, the company is to invest another €9.5m into two research and development projects at the Galway base.